Cited by 114Retinal Diseases and TreatmentsComplement system in diseasesOcular Diseases and Behçet’s Syndrome

Complement component C5a activates ICAM-1 expression on human choroidal endothelial cells

Open access
Skeie, Jessica M., Fingert, John H., Russell, Stephen R., Stone, Edwin M., Mullins, Robert F.·2010·Investigative Opthalmology & Visual Science

Abstract

PURPOSE: The complement system plays a crucial role in the progression of age-related macular degeneration (AMD). In this study, the authors sought to evaluate the pathophysiologic roles of complement components C3a and C5a in the human choroid in AMD. METHODS: Human RPE/choroid was assayed for the presence of C3a and C5a receptors (C3aR and C5aR) using RT-PCR and immunohistochemistry. Choroidal endothelial cell migration and proliferation were evaluated in the presence of C5a. Organ cultures of human choroid were incubated in C5a or bovine serum albumin (BSA) followed by quantitative immunohistochemistry and quantitative PCR for ICAM-1. AMD patients and controls were genotyped at SNPs in the C5R1 and C3AR1 genes. RESULTS: C5aR, but not C3aR, was detected in human choroid. C5a did not promote endothelial cell migration or proliferation. However, choriocapillaris endothelial cells in organ culture responded to C5a by increasing ICAM-1 mRNA and protein. No significant association of SNP genotypes was detected in AMD patients at the C3AR1 and C5R1 genes. CONCLUSIONS: The generation of C5a peptides may lead to activation of choriocapillaris endothelial cells in AMD. Activation of the choroidal endothelium may affect the progression of AMD by recruitment of monocytes, leading to additional sequelae of AMD pathogenesis.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1167/iovs.10-5322

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 63 · Cited by 114

Research works printed but not linked: 2

  1. Walport MJ. Complement: first of two parts. N Engl J Med. 2001; 344:1058 -1066.
  2. Walport MJ. Complement: second of two parts. N Engl J Med. 2001;344:1140 -1144.

Authors
Skeie, J. M., Fingert, J. H., Russell, S. R., Stone, E. M., & Mullins, R. F.
Affiliations
University of Iowa (US)
Venue
Investigative Opthalmology & Visual Science
Published
2010-10-01
Volume
51
Issue
10
Pages
5336
ISSN
  • 0146-0404 (ISSN-L)
  • 1552-5783
OpenAlex
W2073924928
Cited by
114
References
63
Citations by year
2026: 1 · 2025: 4 · 2024: 8 · 2023: 8 · 2022: 8 · 2021: 6 · 2020: 6 · 2019: 6 · 2018: 9 · 2017: 7 · 2016: 11 · 2015: 13 · 2014: 11 · 2013: 3 · 2012: 7
FWCI
5.59
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Investigative Ophthalmology & Visual Science (publishedVersion, cc-by)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Research to Prevent Blindness
  • Macula Vision Research Foundation
  • Directorate for Biological Sciences
  • National Eye Institute (R01EY017451, F32EY022280, EY016822, R01EY016822, EY017451)
  • National Institute of Child Health and Human Development
Topics
  • Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
  • Life Sciences › Immunology and Microbiology › Immunology › Complement system in diseases
  • Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
Keywords
C5a, ICAM-1, choroidal endothelial cells, choriocapillaris, age-related macular degeneration, complement C3a, C5a receptor, C3a receptor, endothelial cell migration, endothelial cell proliferation, C3AR1, single nucleotide polymorphisms, monocyte recruitment
MeSH terms
Cell Movement, Choroid, Endothelium, Vascular, Gene Expression Regulation, Genotype, Humans, Immunohistochemistry, Macular Degeneration, Organ Culture Techniques, Receptors, Complement, RNA, Messenger, Complement C3a, Complement C5a, Intercellular Adhesion Molecule-1, Reverse Transcriptase Polymerase Chain Reaction, Polymorphism, Single Nucleotide, Receptor, Anaphylatoxin C5a

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review